ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 2 filers reported holding ONCOCYTE CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $99,000 | -18.2% | 135,000 | 0.0% | 0.03% | -15.4% |
| Q2 2022 | $121,000 | -39.8% | 135,000 | 0.0% | 0.04% | -33.9% |
| Q1 2022 | $201,000 | -31.4% | 135,000 | 0.0% | 0.06% | -30.6% |
| Q4 2021 | $293,000 | -25.3% | 135,000 | +22.7% | 0.08% | -33.6% |
| Q3 2021 | $392,000 | -37.4% | 110,000 | +0.9% | 0.13% | -38.8% |
| Q2 2021 | $626,000 | +17.0% | 109,000 | +5.8% | 0.21% | -1.4% |
| Q1 2021 | $535,000 | – | 103,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 719,282 | $2,359,245 | 0.35% |
| Defender Capital, LLC. | 114,520 | $357,302 | 0.13% |